Afternoon Review: The Double Creation Index has risen by over 1%, with the medical services, CRO concept, and innovative drug sectors leading in gains.

All three major indices rose collectively in early trading. By the midday break, the Shanghai Composite Index was up 0.42%, the Shenzhen Component Index increased by 0.73%, the ChiNext Index surged 1.61%, the BeiJing Stock Exchange 50 rose 0.51%, and the Sci-Tech Innovation 50 Index jumped 1.9%. The total market turnover reached 1,599.7 billion yuan, an increase of 208.5 billion yuan from the previous day, with over 3,000 stocks declining across the market. In terms of sectors, medical services, CRO concepts, innovative drugs, bioproducts, and cell immunotherapy led the gains; while precious metals, oil and gas exploration and services, industrial metals, real estate, and photovoltaic equipment saw the largest declines. On the market, the innovative drug sector rebounded from its lows, with stocks such as Boji Medical, Wanbang Pharmaceutical, Longshen Rongfa, and New Mileage hitting the daily limit. Shutai Shen, Yaoshi Technology, and Shanghai Kaibao topped the gains. The CPO sector performed actively, with Gongjin Co., Ltd. and Tianyang New Material hitting the limit, while Tianfu Communication once rose over 13%. Jinlu Electronics, Changyingtong, Dekeli, and Juguang Technology also showed significant gains. The computing power leasing sector surged before retreating, with Chengdi Xiangjiang, Liang Technology, Litong Electronics, and Qunxing Toys hitting the daily limit, while Hongjing Technology, King Kong Photovoltaics, and Hanxin Technology had notable gains. The precious metals sector experienced instability and declined, with Xiaocheng Technology, Zhaojin Gold, and Hunan Silver leading the drops. The oil and gas exploration and services sector opened low and continued to decline, with Tongyuan Petroleum, Keli Co., and Beiken Energy experiencing the largest losses.